Effects on the improvement of blood glucose and changes in body composition of oral anti-diabetic drug SGLT2 inhibitor.~ Relevance to the compliance of the diet therapy for diabetes~

Effects on the improvement of blood glucose and changes in body composition of oral anti-diabetic drug SGLT2 inhibitor.~ Relevance to the compliance of the diet therapy for diabetes~ - Effect of SGLT2 inhibitor and diet therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000022738

Enrollment

Registered

2016-06-14

Start date

2015-06-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Outpatients and hospitalized patients in the department of endocrinology and metabolism of Kanazawa Medical University Hospital. The diabetic patiens who have the adaptation for the treatment of SGLT2 inhibitor that was judged by the physician (>=20 and<=80 of age)

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Amount of Parameters of blood glucose (HbA1c, fasting blood glucose, glycoalbumin, insulin,CPR)	—

Secondary

Measure	Time frame
1)Amount of change in Body weight 2)Amount of change in Body composition (fat, muscle etc.) 3)Carbohydrate intake 4)Urinary albumin excretion 5)eGFRcreat (calculation by conversion formula of GFRcreat in Japanese), serum creatinine 6)Urinary L-FABP excretion, serum cystatinC (Cys-C), eGFRcys (calculation by conversion formula of eGFRcys in Japanese) 7)Serum lipid (T-cho, LDL, HDL, TG) 8)Blood pressure, pulse 9)Liver function(AST,ALT,gammaGTP) 10)Uric acid 11)Hematocrit 12)Ketone Body,Lactic acid 13)BDHQ: intake of energy, protein, lipid and dietary fiber, nutritional education	—

Measure

Time frame

1)Amount of change in Body weight 2)Amount of change in Body composition (fat, muscle etc.) 3)Carbohydrate intake 4)Urinary albumin excretion 5)eGFRcreat (calculation by conversion formula of GFRcreat in Japanese), serum creatinine 6)Urinary L-FABP excretion, serum cystatinC (Cys-C), eGFRcys (calculation by conversion formula of eGFRcys in Japanese) 7)Serum lipid (T-cho, LDL, HDL, TG) 8)Blood pressure, pulse 9)Liver function(AST,ALT,gammaGTP) 10)Uric acid 11)Hematocrit 12)Ketone Body,Lactic acid 13)BDHQ: intake of energy, protein, lipid and dietary fiber, nutritional education

—

Countries

Japan

Contacts

Public ContactYuka Kuroshima

Kanazawa Medical University Diabetology and Endocrinology

naipicrc@kanazawa-med.ac.jp076-286-2211

Outcome results